The Association between Serum Total Bile Acid Level and Long-Term Prognosis in Patients with Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention

<div>Kaplan-Meier curve of clinical outcomes judging by TBA levels. Log-rank test was used. (a) Kaplan-Meier survival curve for all-cause mortality judging by TBA levels. (b) Kaplan-Meier survival curve for cardiovascular death judging by TBA levels. (c) Kaplan-Meier survival curve for MACE judging by TBA levels. TBA: total bile acid. Group1: ~3.5, Group2: 3.5 ~ 10, Group3: ~10. MACE: major adverse cardiovascular events.</div>

Disease Markers

fig2

Figure 2

Figure 2: The Association between Serum Total Bile Acid Level and Long-Term Prognosis in Patients with Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention 

Figure 2 | The Association between Serum Total Bile Acid Level and Long-Term Prognosis in Patients with Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention 